Articles

Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study

Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
BC Cancer Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver
Memorial Sloan Kettering Cancer Center, NY
Mayo Clinic, Rochester, NY
Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul
University of Manchester and the Christie NHS Foundation Trust Manchester Academic Health Science Centre, Manchester
John Theurer Cancer Center, NJ
UC Davis Cancer Center, Sacramento, CA
BC Cancer Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver
Genentech, South San Francisco, CA
Olivia Newton-John Cancer Wellness and Research Centre, Austin Health and Department of Clinical Haemotology, Austin Hospital, Heidelberg
Haematology, East Kent Hospitals, Canterbury
Maria Sklodowska-Curie National Research Institute of Oncology, Krakow
Seagen Inc., Bothell, WA
Seagen Inc., Bothell, WA
Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
Research and Innovation Department, A Lacassagne Cancer Centre, Nice
Haematologica Early view Jun 24, 2021 https://doi.org/10.3324/haematol.2021.278438